Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 3Recruiting 2Not yet recruiting 2Completed 2Active not recruiting 2Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2NSCLC 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 115Carboplatin 103Pemetrexed 90Cisplatin 58Paclitaxel 47osimertinib 40Drug Therapy 40Nivolumab 39Docetaxel 35Specimen Handling 33Magnetic Resonance Spectroscopy 28Bevacizumab 26durvalumab 23Gemcitabine 22cemiplimab 21Radiotherapy 20130-nm albumin-bound paclitaxel 20Radiosurgery 19tislelizumab 18atezolizumab 17aflutinib 15Cetuximab 15Immunotherapy 14Immune Checkpoint Inhibitors 14Platinum Compounds 13Ipilimumab 13Biopsy 12Standard of Care 11Surgical Procedures, Operative 10Injections 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Non-Small-Cell Lung × Anterior Temporal Lobectomy × Clear all
NCT07166003 2025-09-10

NeoIP-Lung

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
500 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04944563 2022-04-05

Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
1,120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡